The influence of central corneal thickness (CCT) on intraocular pressure (IOP) is well documented.[@b1-opth-6-871]--[@b3-opth-6-871] In 2005, Luce[@b4-opth-6-871] reported the measurement of corneal resistance factor (CRF) and corneal hysteresis (CH) in vivo. CRF is predominantly a measure of corneal elasticity, and CH is a measure of the viscoelastic parameters of the cornea. Both parameters are measured with the ocular response analyzer (ORA), which fires a precisely metered air pulse that indents the cornea into slight concavity. A brief moment after the cornea is applanated (on its way inward), the air jet is automatically switched off, allowing the cornea to return to its original convex shape. Consequently, the cornea passes through two applanation events -- inward and outward. The difference between both applanation pressures is the corneal hysteresis. The corneal resistance factor is defined as a linear function of both applanation pressures.[@b5-opth-6-871] In addition to the biomechanical parameters of the cornea, the ORA also measures a corneal-compensated IOP (IOPcc) and a Goldmann-correlated IOP (IOPg). The IOPcc takes the corneal hysteresis into account so that, theoretically at least, it is independent of the viscoelastic parameters of the cornea. The IOPg is the average of both applanation pressures.

Interest in the biomechanical parameters of the cornea stem from the fact that central corneal thickness (CCT) is known to influence the IOP measured with several tonometers, including the clinical gold standard Goldmann applanation tonometer (GAT).[@b2-opth-6-871],[@b6-opth-6-871]--[@b13-opth-6-871] Until recently, the only biomechanical parameter that could be assessed in vivo was CCT. Thus, with CH and CRF come two new parameters that could potentially be more influential than CCT on the IOP measured through the cornea.

It is thus important to know if any ORA parameters are influenced by topical anesthetic drops because these are sometimes used before IOP measurements taken with noncontact tonometers (NCTs), especially when the IOPs measured with the NCTs are being compared with devices that make contact with the cornea, thus necessitating topical anesthesia. Such studies usually use topical anesthetics and then randomize the order in which IOP measurements are made.

Ehongo et al[@b14-opth-6-871] investigated the effect of topical anesthesia on ORA parameters. Using both eyes of each of 23 healthy volunteers, they found that 0.4% oxybuprocaine caused statistically significant decreases in IOPcc but not in any other ORA parameter. However, the interpretation of the results of their study is limited by a relatively small sample size, the use of only one anesthetic, measurements that were taken only in one visit, and measurements that were taken at only one time point post instillation (at 2 minutes). Also, only IOPcc not IOPg was reduced, in contrast to a study[@b15-opth-6-871] in 2007 that reported a small but statistically significant and consistent reduction in the IOP measured with a noncontact tonometer and caused by two different anesthetics.

This study sought to address some of the shortcomings of the Ehongo et al[@b14-opth-6-871] study and, in light of the results of AlMubrad and Ogbuehi,[@b15-opth-6-871] to address the hypothesis that topical anesthetics will cause a small but statistically significant reduction of the IOPs measured with the ORA.

Methods
=======

Before inclusion in this study, both eyes of each potential subject were subjected to a comprehensive ophthalmological exam, including slit-lamp biomicroscopy, ophthalmoscopy, visual acuity, refraction, and static perimetry, using the central 30-2 configuration on the Humphrey's automated perimeter. Exclusion criteria were any observable sign or positive history for anterior segment disease or surgery, positive history for intraocular surgery, contact lens wear, prescribed topical medication, or a corneal cylinder ≥4.00DC. Thirty- nine subjects (21 men) completed this study, down from 42 subjects who were selected to participate. In addition to the three subjects lost to follow up, three subjects were excluded from participation (one for contact lens wear and two because of prior laser-assisted in situ keratomileusis (LASIK) surgeries). The ages of the subjects ranged from 20 to 29 years with a mean age (±SD) of 22 (±2) years. Following a detailed explanation of the study and the rights of the subjects who agree to participate, informed consent was obtained from each subject in accordance with the 1975 Helsinki Declaration, as modified in Edinburgh 2000. The study protocol was approved by the research ethics review board of the College of Applied Medical Sciences, King Saud University.

Using a table of random numbers generated on Microsoft Excel, each eye of each subject was randomized into one of three groups in the first measurement session: polyvinyl alcohol (0.5%), tetracaine hydrochloride (0.5%), or oxybuprocaine hydrochloride (0.4%). The groups were not matched for sex or age because, with the narrow age range of the subjects selected for this study, neither age nor sex has been shown to have a significant influence on any of the parameters measured by the ORA. All eye drops were in single dose unit form and were thus preservative free. On the second visit approximately 4 days later, the groups were changed to determine the reproducibility of any observed effects; eyes that were in the polyvinyl alcohol group in session 1 were assigned to the tetracaine group in session 2, those in the tetracaine group in session 1 were assigned to the oxybuprocaine group, and those in the oxybuprocaine group in session 1 were assigned to the polyvinyl alcohol group. In total, 78 eyes of 39 subjects were randomized into three groups, each comprising 26 eyes.

Each subject first had his or her CCT assessed with a Topcon SP3000P specular microscope (Topcon Medical Systems, Paramus, NJ), followed by measurements of IOP and corneal biomechanical parameters with the ORA ( Reichert Ophthalmic Instruments, Depew, NY). In session 2, the order of measurements was the same as in session 1.

Triplicate measurements were made with the specular microscope and averaged to get the mean CCT. Quadruplicate measurements were made with the ORA and averaged to get the mean values for CH and CRF, IOPg, and IOPcc. The four measurements made with the ORA had to be of good quality as described by Luce:[@b4-opth-6-871] "a good bell-shaped pressure signal with tall, relatively equal applanation peaks and relatively smooth raw and filtered applanation signals."

For each subject in each session, the CCT and ORA measurements were repeated twice. The first set of measurements was taken and then one drop of polyvinyl alcohol (0.5%), tetracaine hydrochloride (0.5%), or oxybuprocaine hydrochloride (0.4%) was instilled into the conjunctival sac. The CCT and ORA measurements were repeated 2 minutes and 5 minutes post instillation. Measurements were all made between 12 noon and 2 pm when the IOP is known to be at its lowest and most stable.[@b16-opth-6-871]

Statistical analyses
--------------------

Repeated measures analysis of variance (RM-ANOVA) was used to compare the CCT for each eye before instillation, 2 minutes post instillation, and 5 minutes post instillation. The same comparisons were made for CH, CRF, IOPg, and IOPcc.

When a consistent (between sessions) effect on any ORA parameter was noted, a Bland-Altman[@b17-opth-6-871] analysis of repeatability for that parameter was assessed before instillation 2 minutes post instillation and 5 minutes post instillation to determine whether or not the effect was, at least in part, mediated by an alteration of the repeatability of the ORA measurements. The level of statistical significance for all comparisons in this study was 5%.

Results
=======

[Table 1](#t1-opth-6-871){ref-type="table"} shows the age and gender distribution among the groups. The results show that polyvinyl alcohol (control), tetracaine hydrochloride, and oxybuprocaine hydrochloride had no statistically significant effect on any of the biomechanical parameters of the cornea (CCT, CH, and CRF; [Figures 1](#f1-opth-6-871){ref-type="fig"}--[3](#f3-opth-6-871){ref-type="fig"}, respectively) in either measurement session. The results for the intraocular pressures were less clear.

Two minutes after the eye drops were instilled, there was no statistically significant effect on either IOPg (*P* \> 0.05) or IOPcc (*P* \> 0.05) for polyvinyl alcohol, tetracaine hydrochloride, or oxybuprocaine hydrochloride in either session ([Figures 4](#f4-opth-6-871){ref-type="fig"} and [5](#f5-opth-6-871){ref-type="fig"}).

Five minutes after the eye drops were instilled, polyvinyl alcohol showed no statistically significant effect on either IOPg (*P* \> 0.05) or IOPcc (*P* \> 0.05) in either session. Oxybuprocaine hydrochloride caused a statistically significant (*P* \< 0.05) reduction in IOPg in session 1 only. It had no effect on IOPcc in either session 1 or session 2. Tetracaine hydrochloride caused statistically significant reductions in IOPg in both sessions (*P* \< 0.05). Tetracaine hydrochloride also caused a statistically significant (*P* \< 0.05) reduction in IOPcc in session 1 but not in session 2.

The limits of repeatability (LoR) for IOPg in session 1 ([Figure 6](#f6-opth-6-871){ref-type="fig"}) and session 2 ([Figure 7](#f7-opth-6-871){ref-type="fig"}) showed that LoR was reduced by tetracaine hydrochloride in both sessions. In session 1, the LoR was reduced at both the 2 minute and 5 minute post-instillation time points, while in session 2 the LoR was reduced by tetracaine hydrochloride only at the 5 minute post-instillation time point.

Discussion
==========

The results from this study showed that the topical anesthetics tetracaine hydrochloride (0.5%) and oxybuprocaine hydrochloride (0.4%) did not have any effect on CH, CRF, CCT or IOPcc. However, there were significant effects on IOPg, with tetracaine causing this effect in both measurement sessions but oxybuprocaine causing it only in one session. The results also showed that the effect on IOPg was caused in part by a reduction of the LoR for the IOPg measurements. Polyvinyl alcohol (0.5%) used as control eye drops did not cause any statistically significant change to CCT, CH, CRF, IOPcc, or IOPg.

Topical anesthetics have been reported to cause a significant reduction in the IOP measured with noncontact tonometers. [@b15-opth-6-871] A possible explanation for these effects was that this reduction could have been the result of a tear film destabilization caused by preservatives in the topical anesthetics as theorized by Cho and Brown[@b18-opth-6-871] and by Blades et al.[@b19-opth-6-871] However, all the drops used in this study were in the form of single dose units and were thus preservative free. It seems unlikely, therefore, that the IOP-reducing effect of topical anesthesia is mediated via tear film destabilization caused by preservatives. It is possible that a decrease in eyelid tension induced by topical anesthesia could explain the reduction in IOPg,[@b14-opth-6-871] but that still leaves the questions of why the IOPcc was not affected and why oxybuprocaine hydrochloride caused a decrease in IOPg only in one session. Ehongo et al[@b14-opth-6-871] found discrepancies in the way CRF was altered by topical anesthesia in the right eye versus the left eye of the same subjects. Ogbuehi and AlMubrad[@b20-opth-6-871] found that IOPcc and IOPg read higher than the Goldmann tonometer in one measurement session, and in another session (about 1 week later), both ORA IOPs read lower than the Goldmann. In addition, those authors reported repeatability coefficients (1.96 SD^mean\ difference^) that were much higher for the ORA IOPs than for the Goldmann tonometer and another noncontact tonometer. Also in the same study, the LoR between sessions for the ORA IOPs showed a much greater variation than the LoR for the Goldmann tonometer or the other noncontact tonometer. These findings suggest that the variation in ORA IOP measurements is such that the IOP measured with the ORA may lack short-(repeatability) and long-( reproducibility) term consistency. This would explain the findings of Ehongo et al[@b14-opth-6-871] concerning CRF and those in this study concerning the inconsistent effect of tetracaine hydrochloride on IOPcc and the inconsistent effect oxybuprocaine hydrochloride had on IOPg between sessions.

The results from the current study agree well with those of Baudouin and Gastaud[@b21-opth-6-871] and AlMubrad and Ogbuehi[@b15-opth-6-871] in which the average reductions measured after 2 minutes were 0.76 mmHg and 0.7 mmHg (respectively, for Baudouin and Gastaud[@b21-opth-6-871] and for AlMubrad and Ogbuehi[@b15-opth-6-871]) compared with 0.5 mmHg in this study. At the 5 minute time point, the average reductions in IOP were 1.19 mmHg and 0.9 mmHg, respectively, for Baudouin and Gastaud[@b21-opth-6-871] and for AlMubrad and Ogbuehi[@b15-opth-6-871] compared to 1 mmHg in this study.

In conclusion, the results from this study show that topical anesthesia affects the Goldmann-correlated IOP measured by the ORA but not the corneal-compensated IOP or the corneal biomechanical parameters. The effect of topical anesthesia varies with the anesthetic used, and while this effect was measured as statistically significant in this study, it is small enough that it is probably not clinically relevant.

The limitations of this study are a relatively small sample size and poor generalizability to the wider population because only young oculovisually normal subjects were selected for this study.
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![Average corneal thickness values for session one before, 2 minutes after, and 5 minutes after the instillations of polyvinyl alcohol (0.5%), tetracaine hydrochloride (0.5%), and oxybuprocaine hydrochloride (0.4%).\
**Note:** The *P* values are the results of repeated-measures ANOVA comparisons for each eye drop.\
**Abbreviation:** ANOVA, analysis of variance.](opth-6-871f1){#f1-opth-6-871}

![Average corneal hysteresis values for session one before, 2 minutes after, and 5 minutes after the instillations of polyvinyl alcohol (0.5%), tetracaine hydrochloride (0.5%), and oxybuprocaine hydrochloride (0.4%).\
**Note:** The *P* values are the results of repeated-measures ANOVA comparisons for each eye drop.\
**Abbreviation:** ANOVA, analysis of variance.](opth-6-871f2){#f2-opth-6-871}

![Average corneal resistance factor values for session one before, 2 minutes after, and 5 minutes after the instillations of polyvinyl alcohol (0.5%), tetracaine hydrochloride (0.5%), and oxybuprocaine hydrochloride (0.4%).\
**Note:** The *P* values are the results of repeated-measures ANOVA comparisons for each eye drop.\
**Abbreviation:** ANOVA, analysis of variance.](opth-6-871f3){#f3-opth-6-871}

![Average Goldmann-correlated IOP values for session one before, 2 minutes after, and 5 minutes after the instillations of polyvinyl alcohol (0.5%), tetracaine hydrochloride (0.5%), and oxybuprocaine hydrochloride (0.4%).\
**Note:** The *P* values are the results of repeated-measures ANOVA comparisons for each eye drop.\
**Abbreviations:** ANOVA, analysis of variance; IOP, intraocular pressure.](opth-6-871f4){#f4-opth-6-871}

![Average corneal-compensated IOP values for session one before, 2 minutes after, and 5 minutes after the instillations of polyvinyl alcohol (0.5%), tetracaine hydrochloride (0.5%), and oxybuprocaine hydrochloride (0.4%).\
**Note:** The *P* values are the results of repeated-measures ANOVA comparisons for each eye drop.\
**Abbreviations:** ANOVA, analysis of variance; IOP, intraocular pressure.](opth-6-871f5){#f5-opth-6-871}

![Limits of repeatability for the Goldmann-correlated IOP before (solid black lines with arrow heads), 2 minutes post-instillation (dotted gray lines with diamond heads), and 5 minutes post instillation (dotted lines with round heads) of tetracaine hydrochloride (0.5%) in session 1.\
**Abbreviation:** IOP, intraocular pressure.](opth-6-871f6){#f6-opth-6-871}

![Limits of repeatability for the Goldmann-correlated IOP before (solid black lines with arrow heads), 2 minutes post instillation (dotted gray lines with diamond heads), and 5 minutes post instillation (dotted lines with round heads) of tetracaine hydrochloride (0.5%) in session 2.\
**Abbreviation:** IOP, intraocular pressure.](opth-6-871f7){#f7-opth-6-871}

###### 

Demographic Data of the Subjects

                All groups             Polyvinyl alcohol      Tetracaine             Oxybuprocaine
  ------------- ---------------------- ---------------------- ---------------------- ----------------------
  Gender        42 male eyes *(36f)*   14 male eyes *(12f)*   15 male eyes *(11f)*   13 male eyes *(13f)*
  Age (years)   22.4 ± 2.3             22.7 ± 2.2             22.3 ± 2.2             22.1 ± 2.5

**Notes:** The groups are those for session 1. The ages are reported as mean ± SD Number of female eye are italicized and in brackets.
